Research library
Prepared by Pillar Research
CJC-1295 without DAC
Sources and editorial policyA short-acting GHRH-analogue research designation that must be distinguished analytically from CJC-1295 containing a drug-affinity complex.
Evidence limits
The “no DAC” label is not sufficient by itself to establish sequence or identity. Research interpretation requires the exact material specification and batch-level analytical evidence.
Sources
For current strength, AUD price, purity, batch COA and Australian dispatch, see CJC-1295 No DAC 10mg (CJC-1295 No DAC Peptide) product specifications.